[Form 4] CLOROX CO /DE/ Insider Trading Activity

Rhea-AI Filing Summary

Eric H. Reynolds, EVP and Chief Operating Officer of The Clorox Company (CLX), reported an acquisition of company common stock on 09/16/2025. The Form 4 shows an acquisition of 9,611 shares at a price of $124.85 per share, bringing his beneficial ownership to 63,832 shares following the transaction. The filing also discloses Restricted Stock Units that vest in four equal installments on October 5 of 2026, 2027, 2028, and 2029. The form was signed by an attorney-in-fact on 09/18/2025.

Positive

• Insider acquisition disclosed: Reporting officer acquired 9,611 shares, which can be interpreted as alignment with shareholder interests.
• Clear vesting schedule: Restricted Stock Units vest in four equal installments on October 5 of 2026, 2027, 2028, and 2029, providing transparency on future ownership changes.

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider purchase of 9,611 shares at $124.85 increases executive ownership to 63,832 shares; vesting schedule extends to 2029.

The transaction is a direct acquisition of 9,611 common shares by Eric H. Reynolds at $124.85 per share, raising reported beneficial ownership to 63,832 shares. The disclosure of RSUs vesting in four equal annual installments through 2029 provides clarity on future potential share issuance to the executive. This is a routine executive equity award/settlement and insider purchase disclosure rather than an extraordinary corporate event. All details are expressly disclosed in the Form 4.

Corporate Governance Expert

TL;DR: The filing documents routine executive compensation vesting and a contemporaneous purchase; governance disclosure appears complete.

The Form 4 identifies the reporting person as EVP and COO and records both a purchase of common stock and the existence of restricted stock units with a clear four-year vesting timetable. The filing is signed by an attorney-in-fact, consistent with delegated filing practices. The disclosure includes transaction date, price, post-transaction holdings, and vesting dates, meeting standard Section 16 reporting elements contained in the submitted document.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Reynolds Eric H

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CA 94612-1888

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP - Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/16/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/16/2025		A(1)		9,611	A	$124.85	63,832	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Restricted Stock Units will vest in 4 equal installments - 1/4 on each of October 5, 2026, 2027, 2028, and 2029.

	By Angela Hilt, Attorney-in-Fact	09/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did the Form 4 for CLX report on 09/16/2025?

The Form 4 reports that Eric H. Reynolds acquired 9,611 shares of Clorox common stock on 09/16/2025 at a price of $124.85 per share.

How many shares does Eric H. Reynolds beneficially own after the reported transaction?

Following the reported transaction, the filing shows he beneficially owns 63,832 shares.

What is the vesting schedule for the Restricted Stock Units disclosed in the Form 4?

The Restricted Stock Units will vest in four equal installments on October 5 of 2026, 2027, 2028, and 2029.

Who signed the Form 4 filing for the reporting person?

The Form 4 was signed by Angela Hilt, Attorney-in-Fact on 09/18/2025.

What is the reporting person's role at The Clorox Company?

The reporting person is identified as Eric H. Reynolds, serving as Executive Vice President - Chief Operating Officer.